CRVO
Price
$10.51
Change
+$0.30 (+2.94%)
Updated
Sep 5 closing price
Capitalization
91.47M
ITRM
Price
$0.68
Change
+$0.05 (+7.94%)
Updated
Sep 5 closing price
Capitalization
30.29M
62 days until earnings call
Interact to see
Advertisement

CRVO vs ITRM

Header iconCRVO vs ITRM Comparison
Open Charts CRVO vs ITRMBanner chart's image
CervoMed
Price$10.51
Change+$0.30 (+2.94%)
Volume$85.58K
Capitalization91.47M
Iterum Therapeutics
Price$0.68
Change+$0.05 (+7.94%)
Volume$492.94K
Capitalization30.29M
CRVO vs ITRM Comparison Chart in %
Loading...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRVO vs. ITRM commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVO is a StrongBuy and ITRM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CRVO: $10.51 vs. ITRM: $0.68)
Brand notoriety: CRVO and ITRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVO: 20% vs. ITRM: 56%
Market capitalization -- CRVO: $91.47M vs. ITRM: $30.29M
CRVO [@Biotechnology] is valued at $91.47M. ITRM’s [@Biotechnology] market capitalization is $30.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVO’s FA Score shows that 0 FA rating(s) are green whileITRM’s FA Score has 1 green FA rating(s).

  • CRVO’s FA Score: 0 green, 5 red.
  • ITRM’s FA Score: 1 green, 4 red.
According to our system of comparison, CRVO is a better buy in the long-term than ITRM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVO’s TA Score shows that 4 TA indicator(s) are bullish while ITRM’s TA Score has 3 bullish TA indicator(s).

  • CRVO’s TA Score: 4 bullish, 4 bearish.
  • ITRM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CRVO is a better buy in the short-term than ITRM.

Price Growth

CRVO (@Biotechnology) experienced а +9.25% price change this week, while ITRM (@Biotechnology) price change was +0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ITRM is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRVO($91.5M) has a higher market cap than ITRM($30.3M). CRVO YTD gains are higher at: 349.145 vs. ITRM (-61.684). ITRM has higher annual earnings (EBITDA): -20.51M vs. CRVO (-24.56M). CRVO has more cash in the bank: 33.5M vs. ITRM (13M). CRVO has less debt than ITRM: CRVO (0) vs ITRM (32.6M). CRVO (0) and ITRM (0) have equivalent revenues.
CRVOITRMCRVO / ITRM
Capitalization91.5M30.3M302%
EBITDA-24.56M-20.51M120%
Gain YTD349.145-61.684-566%
P/E Ratio4.73N/A-
Revenue00-
Total Cash33.5M13M258%
Total Debt032.6M-
FUNDAMENTALS RATINGS
CRVO vs ITRM: Fundamental Ratings
CRVO
ITRM
OUTLOOK RATING
1..100
665
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
87
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
3591
P/E GROWTH RATING
1..100
632
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVO's Valuation (41) in the Biotechnology industry is somewhat better than the same rating for ITRM (87). This means that CRVO’s stock grew somewhat faster than ITRM’s over the last 12 months.

CRVO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ITRM (100). This means that CRVO’s stock grew similarly to ITRM’s over the last 12 months.

CRVO's SMR Rating (98) in the Biotechnology industry is in the same range as ITRM (99). This means that CRVO’s stock grew similarly to ITRM’s over the last 12 months.

CRVO's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for ITRM (91). This means that CRVO’s stock grew somewhat faster than ITRM’s over the last 12 months.

ITRM's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for CRVO (63). This means that ITRM’s stock grew somewhat faster than CRVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRVOITRM
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MIR22.901.91
+9.10%
Mirion Technologies
PXS2.810.04
+1.30%
Pyxis Tankers
HDL19.000.20
+1.09%
Super Hi International Holding Ltd ADR
BNS63.44-0.11
-0.17%
Bank of Nova Scotia
MBCN30.29-0.61
-1.97%
Middlefield Banc Corp

CRVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVO has been loosely correlated with TCRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVO jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
+2.94%
TCRX - CRVO
34%
Loosely correlated
+1.06%
LVTX - CRVO
32%
Poorly correlated
+1.29%
AGIO - CRVO
30%
Poorly correlated
-0.33%
ONC - CRVO
26%
Poorly correlated
+7.24%
ITRM - CRVO
25%
Poorly correlated
+7.31%
More

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with GLUE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
+7.31%
GLUE - ITRM
40%
Loosely correlated
+0.61%
ACRS - ITRM
34%
Loosely correlated
+1.45%
TARA - ITRM
31%
Poorly correlated
-0.63%
IBRX - ITRM
26%
Poorly correlated
+0.42%
ANAB - ITRM
25%
Poorly correlated
+3.84%
More